# 2276 Surgical Results in Patients with Hepatitis Virus Related
Hepatocellular Carcinoma in Taiwan.
Miin-Fu Chen, Wei-Chen Lee, Long-Bin Jeng, Taipei, Taiwan, ROC
To evaluate the surgical results in patients with hepatitis virus related hepatocellular
carcinoma (HCC), 252 patients, 196 male and 56 female, who
had undergone hepatic resection for HCC from March, 1992, to August,
1998, with complete profiles of hepatis virus markers study were reviewed.
The patients were divided into 4 groups, 30 patients (11.9%) without neither
hepatitis B surface antigen (HBsAg) or anti-hepatitis C antibody (Anti-
HCV Ab) (N-HCC group), 133 patients (52.8%) with positivity of HBsAg
only (B-HCC group), 66 patients (26.2%) with positivity of Anti-HCV Ab
only (C-HCC group), and 23 patients (9.1%) with positivity of either HBsAg
and anti-HCV Ab (BC-HCC group). Compared to the patients in other
groups, the patients in C-HCC group were older and were associated with
more severe cirrhotic change of the liver. The surgical complication rates
and hospital mortalities in C-HCC and BC-HCC groups were 30.3%, 12.1%
and 30.4%, 17.4%, respectively, which were higher than those of N-HCC
(13.3%, 3.3%) and B-HCC (15.8%, 3.8%) groups. The mean disease-free
survival for N-HCC, B-HCC, C-HCC and BC-HCC groups were 31.4 months,
25.4 months, 38.9 months and 13.8 months, respectively. The difference
between these four groups was statistically significant (p < 0.05). However,
the mean overall survival time, 38.3 months for N-HCC group, 37.2 months
for B-HCC group, 52.1 months for C-HCC group, and 32.7 months for BCHCC
group, were not different statistically (p=0.146). In conclusion, the
surgical treatment for HCC related to hepatitis C or dual hepatitis B and C
were associated with higher surgical complication rate and hospital mortalities.
Hepatocellular carcinoma-related to dual hepatitis B and C infection
recurred earlier after hepatectomies. But, the overall survival between
these four groups was not different statistically.
|